Raphael Itzykson is Professor of Hematology at Université Paris Cité, and member of the Hematology Department of Hôpital Saint-Louis in Paris, France. His research focuses on the use of precision medicine tools in AML and on the treatment of CMML. Pr Itzykson has published more than a hundred articles in peer-reviewed journals. He is an active member of the GFM (Groupe Francophone des Myelodysplasies) and ALFA (Acute Leukemia French Association) cooperative groups.